Beacon Health Options’ new Oakland, CA office sits literally and figuratively at the intersection of health care and technology.
To one side of our building stands Kaiser’s corporate headquarters. To the other side stand towers occupied by San Francisco’s spreading tech boom, including Uber’s new office. It’s a fitting metaphor for where Beacon stands as well – at a point of transition to a world where technology is an essential enabler of services.
If you have read Beacon Health Options’ white paper, “Integration,” you learned that more than half of all adults with major depressive disorder are already managed in primary care settings.
You also learned that most antidepressant medications are written by primary care physicians (PCPs). However, most concerning is that approximately 45 percent of those who complete suicide have seen their PCP within the past month.
When it comes to government funding for mental health services, there’s good news and some bad news.
The good news is that the federal government is putting its money where its mouth is. President Obama recently announced that the administration is proposing for 2017 the expenditure of $500 million for a series of two-year mental health initiatives and $1.1 billion for new addiction treatment, prevention and recovery programs.
Maternal depression screening is the way to go.
Health care delivery is generally complicated, but it doesn’t always have to be. Change can occur through a simple step. Take the case of maternal depression. It is undisputed that depression is a highly treatable medical condition, especially if identified and treated early.
“A riddle wrapped in a mystery inside an enigma” was how Winston Churchill described Russia’s position at the outset of World War II.
A statement that still rings true about our understanding of schizophrenia after more than 100 hundred years of research. While hints have appeared from time to time – autoimmunity, brain connectivity, genetics, age of onset – they seem to elude a synthesis that could help us make sense of this devastating psychiatric disorder.
Editor’s note: Jeremy Hastings, Beacon’s Vice President of Corporate Strategy, wrote a blog piece posted on Tuesday, Oct. 27, about how the future’s unknowns present challenges in building and implementing value-based payments (VBPs). His post this week follows up to describe in detail the inherent difficulties in setting up a single provider in a VBP. However, in spite of the hard work required to establish VBPs, it is not only possible, but also critical, to do. Value-based payments (VBPs) are one of the next frontiers for innovation in health care. In behavioral health, the innovation is coming, but inertia is a powerful force that needs to be overcome. Some of this inertia is entirely appropriate, as changing a decades-long reimbursement…
Television and film provide a surprising glimpse into the past and future. Consider the much-loved Back to the Future, where Marty McFly travels to October 2015 from his cozy 1985 confines. In an unscientific way, I spent some time looking at the first few scenes in the movie’s fictitious 2015 to compare them with how life actually turned out. VBPs are payer-provider contracts structured to provide payment and/or incentives for better outcomes. Today, 95 percent or more of our provider contracts are in pay for volume fee-for-service structures (not VBPs). Our crystal ball writers would probably score 25-30 percent on future predictability, with the huge misses being flying cars; hoverboards (this one is close as there are self-propelled skateboards, they…
The term “behavioral health” is about just exactly that – human behavior and its healthy alignment with the world. However, ironically, the very industry to improve behavioral health is way behind other industries in changing behavior. Consider the advertising industry: every day we are bombarded by sales tactics. Commercials on TV, ads on public transit, billboards on highways, grocery store aisle layouts, all of these add up to an all-out assault on our minds. Sometimes the target is our pocketbooks (think about the GEICO commercials); sometimes it is our actions (“smoking kills” campaigns in the 90s and 00s). Today, though, the tactics are more specific, focused, and nuanced than ever. The old-school way of behavior change was successful because it…
Has public opinion trumped the rigors of the scientific method – clinically sound research that supports or negates the efficacy of marijuana for medical use? A recent issue of the Journal of the American Medical Association (JAMA) devoted two extensive clinical reviews, a research letter, an editorial and a patient page to topics related to medical marijuana. The reviews lay bare what is at the heart of the medical marijuana debate for the health care industry: Has public opinion trumped the rigors of the scientific method – clinically sound research that supports or negates the efficacy of marijuana for medical use? There are downstream effects of the legalization of medical marijuana that are not specifically related to efficacy or safety….